SETD2 loss promotes the occurrence and development of hepatocellular carcinoma (HCC), and therefore, further studies on the role of SETD2 and cholesterol homeostasis in tumorigenesis are warranted. This evidence concerns the gene SETD2 and hepatocellular carcinoma.